# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-15-001629
Filing Date
2015-03-09
Accepted
2015-03-09 17:18:52
Documents
17
Period of Report
2014-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | a2014-10k.htm | 10-K | 1842186
2 | EXHIBIT 10.11 | a2014-10kxexhibit1011ajkaz.htm | EX-10.11 | 41216
3 | EXHIBIT 10.12 | a2014-10kxexhibit1012marti.htm | EX-10.12 | 41133
4 | EXHIBIT 10.13 | a2014-10kxexhibit1013leopa.htm | EX-10.13 | 41086
5 | EXHIBIT 10.14 | a2014-10kxexhibit1014rickg.htm | EX-10.14 | 42495
6 | EXHIBIT 10.15 | a2014-10kxexhibit1015jimhe.htm | EX-10.15 | 42595
7 | EXHIBIT 23.1 | a2014-10kxexhibit231consen.htm | EX-23.1 | 4204
8 | EXHIBIT 31.1 | a2014-10kxexhibit311.htm | EX-31.1 | 18724
9 | EXHIBIT 31.2 | a2014-10kxexhibit312.htm | EX-31.2 | 18769
10 | EXHIBIT 32.1 | a2014-10kxexhibit321.htm | EX-32.1 | 9001
17 |  | a2014-10k_chartx32426.jpg | GRAPHIC | 63089
| Complete submission text file | 0001628280-15-001629.txt |  | 12064684

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
11 | XBRL INSTANCE DOCUMENT | cpix-20141231.xml | EX-101.INS | 1763229
12 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | cpix-20141231.xsd | EX-101.SCH | 79583
13 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | cpix-20141231_cal.xml | EX-101.CAL | 105100
14 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | cpix-20141231_def.xml | EX-101.DEF | 347999
15 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | cpix-20141231_lab.xml | EX-101.LAB | 872506
16 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | cpix-20141231_pre.xml | EX-101.PRE | 507269

Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 10-K | Act: 34 | File No.: 001-33637 | Film No.: 15686129
SIC: 2834 Pharmaceutical Preparations